Home
FDA Calendar
About & More
Testimonials
Useful Links
Our Disclaimer
Updates and Roadmap
Contribute
Create Company Profile
Create Drug Profile
Browse
Contact
FDA Calendar for Genta Incorporated (GETA.OB)
Login Now
|
Register (free)
Genta Incorporated (Genta), is a biopharmaceutical company engaged in pharmaceutical (drug) research and development. The Company focuses on the identification, development and commercialization of drugs for the treatment of cancer and related diseases. Genta’s research portfolio consists of two major programs: Deoxyribonucleic Acid (DNA)/Ribonucleic Acid (RNA) Medicines and Small Molecules. The DNA/RNA Medicines program includes drugs that are based on using modifications of either DNA or RNA as drugs that can be used to treat disease. This program includes technologies, such as antisense, decoys and small interfering or micro RNAs. Genta’s drug from this program is an investigational antisense compound known as Genasense (oblimersen sodium injection). The Small Molecules program includes drugs, such as Ganite and investigational compounds tesetaxel and G4544.
Around The Net
Latest News
Twitter Stream
Yahoo Message Board
Google Message Board
You are reading news provided by a variety of web sources.
Drug Pipeline
Drug Name
Type Of Drug
FDA Status
Drug Phase
Tesetaxel
Cancer
Fast Track
Phase 2
Events
No future events listed at this time, please check back later.
1 past event(s) found.
Click here
to view them.
Outcome
Past Events
Genta Incorporated
06/07/2010
Past Event
Other:
An inter-subject dose-escalation study of tesetaxel administered orally once every 3 weeks and once weekly for 3 consecutive weeks in patients with advanced or metastatic solid tumors. Poster session at the 2010 Annual ASCO Meeting.
(relates to the drug
Tesetaxel
)
Add New Event
In order to write a comment you must first login.
Login
or
Register
(for free!)
Add Event
Important Links
No links found.
Add New Link
In order to write a comment you must first login.
Login
or
Register
(for free!)
Add Link
$0.00
0
1/1/0001 12:00:00 AM
Sponsors
Other Links
Corporate Website
Analyst Estimates (MarketWatch)
CNN Money
Google Finance
Guru Focus
Major Holders
MSN Money
SEC Filings (EDGAR Online)
Seeking Alpha
Yahoo! Finance